Literature DB >> 12363392

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia.

Yukihiko Shirayama1, Kenji Hashimoto, Yoshio Suzuki, Teruhiko Higuchi.   

Abstract

The authors examined the correlations among plasma levels of ACTH, cortisol, progesterone, testosterone, and dehydroepiandrosterone sulfate (DHEA-S) and their relationship with the scales for assessment of negative symptoms (SANS) in the male schizophrenic patients with negative symptoms. The subjects were 28 male schizophrenic patients categorized as with low negative symptoms (N = 14) and with moderate negative symptoms (N = 14) and 13 healthy subjects. Plasma levels of neurosteroids were measured by radioimmunoassay. Significant correlations of SANS scores with plasma levels of ACTH, cortisol and testosterone, but not progesterone and DHEA-S, were found in the male schizophrenic patients. Furthermore, plasma levels of ACTH, cortisol, and testosterone in the male schizophrenic patients with moderate negative symptoms, but not low negative symptoms, were significantly different from normal controls. The measurements of plasma neurosteroid levels could be a useful biological marker for the severity of negative symptoms in schizophrenic patients. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363392     DOI: 10.1016/s0920-9964(01)00367-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis.

Authors:  Emilio Fernandez-Egea; Clemente García-Rizo; Brian Miller; Eduard Parellada; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

2.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

3.  Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

Authors:  Roberto Frau; Federico Abbiati; Valentina Bini; Alberto Casti; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

4.  Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Authors:  HuaLin Cai; Xiang Zhou; George G Dougherty; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Matcheri Keshavan; Jeffrey K Yao
Journal:  Psychoneuroendocrinology       Date:  2018-02-07       Impact factor: 4.905

Review 5.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

6.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

7.  Estrogen is necessary for 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) infusion to the ventral tegmental area to facilitate social and sexual, but neither exploratory nor affective behavior of ovariectomized rats.

Authors:  C A Frye; J J Paris; M E Rhodes
Journal:  Pharmacol Biochem Behav       Date:  2008-08-23       Impact factor: 3.533

8.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

9.  Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice.

Authors:  Cheryl A Frye; Ichiro Sora
Journal:  Behav Brain Res       Date:  2010-01-20       Impact factor: 3.332

10.  Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors.

Authors:  Seo-Yeon Yoon; Dae-Hyun Roh; Hyoung-Sig Seo; Suk-Yun Kang; Ho-Jae Han; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.